43 related articles for article (PubMed ID: 22819377)
21. The application of botulinum toxin in the prostate.
Chuang YC; Chancellor MB
J Urol; 2006 Dec; 176(6 Pt 1):2375-82. PubMed ID: 17085104
[TBL] [Abstract][Full Text] [Related]
22. Perspective of Botox for treatment of male lower urinary tract symptoms.
Ilie CP; Chancellor MB
Curr Opin Urol; 2009 Jan; 19(1):20-5. PubMed ID: 19057212
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of botulinum toxin injection for benign prostatic hyperplasia: a systematic review and meta-analysis.
Shim SR; Cho YJ; Shin IS; Kim JH
Int Urol Nephrol; 2016 Jan; 48(1):19-30. PubMed ID: 26560471
[TBL] [Abstract][Full Text] [Related]
24. [What role does botulinum toxin play in the treatment of benign prostatic hyperplasia?].
Mazdar A; Bedouche A; Zoughari S; Ibrahimi A; Sayegh HE; Iken A; Benslimane L; Nouini Y
Pan Afr Med J; 2016; 24():309. PubMed ID: 28154664
[TBL] [Abstract][Full Text] [Related]
25. Botulinum toxin for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia.
Antunes AA; Srougi M; Coelho RF; de Campos Freire G
Nat Clin Pract Urol; 2007 Mar; 4(3):155-60. PubMed ID: 17347660
[TBL] [Abstract][Full Text] [Related]
26. Intraprostatic Botulinum Neurotoxin Type A Injection for Benign Prostatic Hyperplasia-A Spotlight in Reality.
Hsu YC; Wang HJ; Chuang YC
Toxins (Basel); 2016 Apr; 8(5):. PubMed ID: 27128942
[TBL] [Abstract][Full Text] [Related]
27. The use of botulinum toxin in benign prostatic hyperplasia.
Marchal C; Perez JE; Herrera B; Machuca FJ; Redondo M
Neurourol Urodyn; 2012 Jan; 31(1):86-92. PubMed ID: 21905088
[TBL] [Abstract][Full Text] [Related]
28. Clinical and experimental studies of benign prostatic hyperplasia.
Coffey DS; Walsh PC
Urol Clin North Am; 1990 Aug; 17(3):461-75. PubMed ID: 1695775
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological treatment for common prostatic conditions in dogs - benign prostatic hyperplasia and prostatitis: an update.
Niżański W; Levy X; Ochota M; Pasikowska J
Reprod Domest Anim; 2014 Jun; 49 Suppl 2():8-15. PubMed ID: 24947855
[TBL] [Abstract][Full Text] [Related]
30. Botulinum toxin A in prostate disease: a venom from bench to bed-side.
Mearini L; Giannantoni A
Curr Drug Deliv; 2012 Jan; 9(1):85-94. PubMed ID: 22409179
[TBL] [Abstract][Full Text] [Related]
31. Canine prostate models in preclinical studies of minimally invasive interventions: part II, benign prostatic hyperplasia models.
Sun F; Báez-Díaz C; Sánchez-Margallo FM
Transl Androl Urol; 2017 Jun; 6(3):547-555. PubMed ID: 28725598
[TBL] [Abstract][Full Text] [Related]
32. Canine Prostate Disease.
Christensen BW
Vet Clin North Am Small Anim Pract; 2018 Jul; 48(4):701-719. PubMed ID: 29933768
[TBL] [Abstract][Full Text] [Related]
33. Potential role of oxidative stress in pathogenesis of benign prostatic hyperplasia in male dogs.
Domosławska-Wyderska A; Zduńczyk S; Rafalska A
Reprod Domest Anim; 2024 May; 59(5):e14580. PubMed ID: 38698701
[TBL] [Abstract][Full Text] [Related]
34. Botulinum A toxin for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms.
Thomas CA; Chuang YC; Giannantoni A; Chancellor MB
Curr Urol Rep; 2006 Jul; 7(4):266-71. PubMed ID: 16930497
[TBL] [Abstract][Full Text] [Related]
35. Advances in Prostatic Diagnostics in Dogs: The Role of Canine Prostatic Specific Esterase in the Early Diagnosis of Prostatic Disorders.
Alonge S; Melandri M; Aiudi G; Lacalandra GM
Top Companion Anim Med; 2018 Dec; 33(4):105-108. PubMed ID: 30502858
[TBL] [Abstract][Full Text] [Related]
36. Clinical approach to prostatic diseases in the dog.
Cunto M; Mariani E; Anicito Guido E; Ballotta G; Zambelli D
Reprod Domest Anim; 2019 Jun; 54(6):815-822. PubMed ID: 30974484
[TBL] [Abstract][Full Text] [Related]
37. Intra-prostatic injection of botulinum toxin type A in treatment of dogs with spontaneous benign prostatic hyperplasia.
Mostachio GQ; Apparício M; Motheo TF; Alves AE; Vicente WR
Anim Reprod Sci; 2012 Aug; 133(3-4):224-8. PubMed ID: 22819377
[TBL] [Abstract][Full Text] [Related]
38. Botulinum neurotoxin A for benign prostatic hyperplasia.
Oeconomou A; Madersbacher H
Curr Opin Urol; 2010 Jan; 20(1):28-36. PubMed ID: 19887944
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
